Search for: "Astellas Pharma US, Inc." Results 1 - 20 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2014, 8:26 pm by Ben Vernia
Astellas Pharma US Inc., located in Northbrook, Ill., manufactures and sells pharmaceutical drugs, including Mycamine [read post]
7 Nov 2010, 9:59 pm by Patent Docs
Inc. 1:10-cv-08274; filed November 2, 2010 in the Southern District of New York • Plaintiffs: Astellas US LLC; Astellas Pharma Inc. [read post]
7 Feb 2016, 9:59 pm by Patent Docs
Apotex Inc. et al. 1:15-cv-00857; filed September 22, 2015 in the District Court of Delaware • Plaintiffs: Astellas Pharma Inc.; Astellas US LLC; Astellas Pharma US, Inc. [read post]
3 Jun 2012, 8:34 pm by Patent Docs
Hospira Inc. 1:12-cv-00652; filed May 23, 2012 in the District Court of Delaware • Plaintiffs: Astellas US LLC; Astellas Pharma US, Inc.; Item Development AB • Defendant: Hospira Inc. [read post]
5 Feb 2014, 2:16 am
Case C-661/13 Astellas Pharma Inc, a reference for a preliminary ruling to the Court of Justice of the European Union (CJEU) from the Oberlandesgericht Düsseldorf, Germany, came into the IPKat's line of vision in mid-January thanks to katfriend Paul England (see earlier Katpost here). [read post]
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
District Court for the District of Massachusetts has denied the motion to dismiss filed in the consolidated class action of In re Prograf Antitrust Litigation by the defendant, organ transplant drug manufacturer Astellas Pharma US, Inc. [read post]
28 Apr 2020, 11:46 pm by Brian Cordery (Bristows)
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
29 Jun 2011, 3:34 am by Marie Louise
(Spicy IP) Indonesia’s pharma IP problems (IP Komodo) US: House Patent Reform Bill, HR 1249, still has the Administration’s and BIO’s support (BIOtechNow) (Patent Baristas) US: Supreme Court takes two more patent cases: Kappos v Hyatt; Caraco v Novo Nordisk (Patently-O) US: Patent Profile: Antisense Pharma secures patents for convection enhanced delivery (Patent Docs)   Products Adenoscan (Adenosine) – US: Patent… [read post]
26 Feb 2009, 5:54 am
My fellow panellists were in-house counsel from Merck & Co., Inc., Pfizer Inc. and Astellas Pharma Canada Inc. [read post]
14 Oct 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
5 Aug 2009, 5:35 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California… [read post]